Finnish manufacturing facility to get €50m expansion
The planned €50 million investment at the Finland-based CDMO facility…
The planned €50 million investment at the Finland-based CDMO facility will enable advanced technologies to be used for development and manufacture of advanced therapy medicinal products (ATMPs).